{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:30Z","timestamp":1772120070065,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Trinity Health of New England"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40121-020-00341-2","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T02:02:32Z","timestamp":1600567352000},"page":"913-926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase\u00a0II Clinical Trial"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1359-0014","authenticated-orcid":false,"given":"Danyal","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha","family":"Dulipsingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Zapatka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reginald","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy B.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Puff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed A.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,20]]},"reference":[{"key":"341_CR1","unstructured":"Johns Hopkins University & Medicine. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https:\/\/coronavirus.jhu.edu\/map.html.\u00a0Accessed 6 Sept 2020."},{"key":"341_CR2","unstructured":"Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html. Accessed 3 Aug 2020."},{"key":"341_CR3","doi-asserted-by":"publisher","unstructured":"He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.26326.","DOI":"10.1002\/jmv.26326"},{"issue":"4","key":"341_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/jcm9040967","volume":"9","author":"M Park","year":"2020","unstructured":"Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967.","journal-title":"J Clin Med"},{"issue":"5","key":"341_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/oby.22809","volume":"28","author":"JF Gautier","year":"2020","unstructured":"Gautier JF, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity (Silver Spring). 2020;28(5):848.","journal-title":"Obesity (Silver Spring)"},{"key":"341_CR6","doi-asserted-by":"crossref","unstructured":"Lu L, Zhang H, Zhan M, et al. Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm? Front Cell Dev Biol. 2020;8:677.","DOI":"10.3389\/fcell.2020.00677"},{"issue":"5","key":"341_CR7","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al. Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139.","journal-title":"J Clin Invest"},{"key":"341_CR8","doi-asserted-by":"crossref","unstructured":"Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261\u20137.","DOI":"10.1097\/CM9.0000000000000824"},{"issue":"9","key":"341_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/CM9.0000000000000775","volume":"133","author":"W Liu","year":"2020","unstructured":"Liu W, Tao ZW, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"341_CR10","doi-asserted-by":"crossref","unstructured":"Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia. 2020;75(10):1340\u20139.","DOI":"10.1111\/anae.15201"},{"issue":"1","key":"341_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-020-03006-1","volume":"24","author":"P Quah","year":"2020","unstructured":"Quah P, Li A, Phua J. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care. 2020;24(1):285.","journal-title":"Crit Care"},{"key":"341_CR12","doi-asserted-by":"crossref","unstructured":"Chen J, Qi T, Liu L, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):e1\u2013e6.","DOI":"10.1016\/j.jinf.2020.03.004"},{"key":"341_CR13","doi-asserted-by":"publisher","unstructured":"Bonow RO, Hernandez AF, Turakhia M. Hydroxychloroquine, coronavirus disease 2019, and QT prolongation. JAMA Cardiol. 2020.. https:\/\/doi.org\/10.1001\/jamacardio.2020.1782.","DOI":"10.1001\/jamacardio.2020.1782"},{"key":"341_CR14","doi-asserted-by":"publisher","unstructured":"Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3596.","DOI":"10.1001\/jamainternmed.2020.3596"},{"key":"341_CR15","unstructured":"US Department of Health and Human Services Food and Drug Administration (FDA). Investigational COVID-19 convalescent plasma: emergency INDs. March 2020. https:\/\/www.fda.gov\/vaccines-blood-biologics\/investigational-new-drug-ind-or-device-exemption-ide-process-cber\/investigational-covid-19-convalescent-plasma. Accessed 10 Apr 2020."},{"issue":"1","key":"341_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jiu396","volume":"211","author":"J Mair-Jenkins","year":"2015","unstructured":"Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211(1):80\u201390.","journal-title":"J Infect Dis"},{"key":"341_CR17","doi-asserted-by":"crossref","unstructured":"Sun M, Xu Y, He H, et al. Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy. Int J Infect Dis. 2020;98:334\u201346.","DOI":"10.1016\/j.ijid.2020.06.107"},{"issue":"8","key":"341_CR18","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.18632\/aging.103102","volume":"12","author":"L Zhang","year":"2020","unstructured":"Zhang L, Pang R, Xue X, et al. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19. Aging (Albany NY). 2020;12(8):6536\u201342.","journal-title":"Aging (Albany NY)"},{"key":"341_CR19","doi-asserted-by":"crossref","unstructured":"Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117(17):9490\u20136.","DOI":"10.1073\/pnas.2006961117"},{"issue":"16","key":"341_CR20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2020.4783","volume":"323","author":"C Shen","year":"2020","unstructured":"Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582\u20139.","journal-title":"JAMA"},{"key":"341_CR21","doi-asserted-by":"crossref","unstructured":"Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324(5):460\u201370.","DOI":"10.1001\/jama.2020.12607"},{"key":"341_CR22","doi-asserted-by":"crossref","unstructured":"Joyner MJ, Wright RS, Fairweather D, et al. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020;130(9):4791\u20137.","DOI":"10.1172\/JCI140200"},{"key":"341_CR23","doi-asserted-by":"crossref","unstructured":"Joyner MJ, Bruno KA, Klassen SA, et al. Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc. 2020;95(9):1888\u201397.","DOI":"10.1016\/j.mayocp.2020.09.032"},{"key":"341_CR24","doi-asserted-by":"publisher","unstructured":"Hartman WR, Hess AS, Connor JP. Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the midwest. Res Sq. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-39447\/v1.","DOI":"10.21203\/rs.3.rs-39447\/v1"},{"key":"341_CR25","doi-asserted-by":"crossref","unstructured":"Salazar E, Perez KK, Ashraf M, et al. Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma. Am J Pathol. 2020;190(8):1680\u201390.","DOI":"10.1016\/j.ajpath.2020.05.014"},{"key":"341_CR26","unstructured":"US Department of Health and Human Services Food and Drug Administration (FDA). COVID-19: developing drugs and biological products for treatment or prevention guidance for industry, May 2020. https:\/\/www.fda.gov\/media\/137926\/download. Accessed 26 July 2020."},{"key":"341_CR27","unstructured":"Salazar E, Christensen PA, Graviss EA, et al. Treatment of COVID-19 patients with convalescent plasma reveals a signal of significantly decreased mortality. Am J Pathol. 2020:S0002-9440(20)30370-9."},{"key":"341_CR28","doi-asserted-by":"crossref","unstructured":"Perotti C, Baldanti F, Bruno R, et al. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.\u00a0Haematologica. 2020:261784.","DOI":"10.1101\/2020.05.26.20113373"},{"key":"341_CR29","doi-asserted-by":"publisher","unstructured":"Joyner MJ, Senefeld JW , Klassen SA, et al. Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience. medRxiv. https:\/\/doi.org\/10.1101\/2020.08.12.20169359.","DOI":"10.1101\/2020.08.12.20169359"},{"key":"341_CR30","doi-asserted-by":"crossref","unstructured":"Rojas M, Rodr\u00edguez Y, Monsalve DM, et al. Convalescent plasma in Covid-19: possible mechanisms of action. Autoimmun Rev. 2020:102554.","DOI":"10.1016\/j.autrev.2020.102554"},{"key":"341_CR31","unstructured":"Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020:3539."},{"issue":"20","key":"341_CR32","first-page":"30316","volume":"S2213\u20132600","author":"C Karagiannidis","year":"2020","unstructured":"Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10\u2008021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;S2213\u20132600(20):30316\u20137.","journal-title":"Lancet Respir Med"},{"key":"341_CR33","unstructured":"Intensive Care National Audit Research Center (ICNARC). ICNARC report on COVID-19 in critical care, July 2020. https:\/\/www.icnarc.org\/DataServices\/Attachments\/Download\/. Accessed 6 Sep 2020."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-020-00341-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T19:29:23Z","timestamp":1632079763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-020-00341-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s40121-020-00341-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.27.20183293","asserted-by":"object"}]},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,20]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}